To unsubscribe from the IAS Mailing List, please scroll down to end of email.

IAS Logo

International Atherosclerosis
Society
Literature e-Newsletter
November 2007

Stethoscope, medicine, world, fruit, lab

SEARCH TOPICS
 
PAGE 1

Apo / Lipoproteins
Biomarkers
Diabetes
Drug Therapy
Gender

Genetics of CVD
Imaging
Immunology
Inflammation
Lipid Metabolism

Liver Disease
Menopause
Metabolic Syndrome
Nutrition and Diet
Obesity


IAS AFFILIATIONS

International Chair on Cardiometabolic Risk

Metabolic Syndrome Institute


IAS WEBSITE EDITORIAL BOARD
Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors Stefano Bellosta
Milan, Italy
Emanuela Folco
Milan, Italy
Ann Jackson
Houston, TX, USA

Website Editors Gianpaolo Bagnato
Milan, Italy
Annamaria Scimone
Milan, Italy
Mandi Wong
Dallas, TX, USA


JOIN THE MAILING LIST

To receive the IAS
e-Newsletter and IAS Literature e-Newsletter, please send an email to
ias@utsouthwestern.edu

To be removed for the IAS Mailing List, please send an email to ias@utsouthwestern.edu and put "REMOVE" in the subject








Apo / Lipoproteins

  • High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis:
    A systematic review.

    (Amarenco P, et.al. Atherosclerosis. 2007 Oct 6; [Epub ahead of print])
    View Abstract
  • Association between circulating oxidized low-density lipoprotein and fibro-calcific remodeling of the aortic valve in aortic stenosis.
    (Cote C, et.al. Heart. 2007 Oct 11; [Epub ahead of print])
    View Abstract
  • A novel method for production of lipid hydroperoxide- or oxysterol-rich low-density lipoprotein.
    (Gerry AB, et.al. Atherosclerosis. 2007 Oct 16; [Epub ahead of print])
    View Abstract

> top

Biomarkers

  • Can gamma-Glutamyltransferase be an Additional Marker of Arterial Stiffness?
    (Song SH, et.al. Circ J. 2007 Nov;71(11):1715-20.)
    View Abstract
  • Soluble CD40L Versus Myocyte Enhancer Factor: Predicting a Prominent Marker For Cardiovascular Disease.
    (de Trad CH.Conf Proc IEEE Eng Med Biol Soc. 2006;1:1698-701.)
    View Abstract
  • Non-traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ?
    (Konstantino Y, et.al. Acute Card Care. 2007 Oct 8;:1-10 [Epub ahead of print])
    View Abstract

> top

Diabetes

  • Nfluence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus.
    (Bogdanski P, et.al. Int J Clin Pharmacol Ther. 2007 Oct;45(10):563-7.)
    View Abstract
  • Revascularization in high risk patients: diabetes mellitus.
    (Cola C, et.al. Minerva Cardioangiol. 2007 Oct;55(5):557-77.)
    View Abstract
  • Adipokines in diabetes and cardiovascular diseases.
    (Kralisch S, et.al. Minerva Endocrinol. 2007 Sep;32(3):161-71.)
    View Abstract
  • Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    (Liang KW, et.al. Clin Chim Acta. 2007 Oct 10; [Epub ahead of print])
    View Abstract
  • Macrovascular component of diabetes atherosclerosis and insulin (CUPS-18).
    (Mohan V.J Assoc Physicians India. 2007 Jul;55 Suppl:13-8. Review. No abstract available.)
    View Abstract
  • Endothelial Dysfunction and CRP Are Risk Factors for Diabetes in Essential Hypertension.
    (Perticone F, et.al. Diabetes. 2007 Oct 10; [Epub ahead of print])
    View Abstract
  • Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.
    (Rahman S, et.al. Diabetes Obes Metab. 2007 Nov;9(6):767-80.)
    View Abstract
  • Regulation of Src homology 2-containing protein tyrosine phosphatase by advanced glycation end products: the role on atherosclerosis in diabetes.
    (Seki N, et.al. Metabolism. 2007 Nov;56(11):1591-8.)
    View Abstract
  • Diabetes and the heart: could the diabetic myocardium be protected by preconditioning?
    (Vinokur V, et.al. Redox Rep. 2007;12(6):246-56.)
    View Abstract
  • Noninvasive measures of cardiovascular changes in diabetes mellitus.
    (Wadwa RP.Curr Opin Endocrinol Diabetes Obes. 2007 Aug;14(4):263-8.)
    View Abstract
  • Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus.
    (Wakabayashi I, et.al. J Thromb Thrombolysis. 2007 Oct 11; [Epub ahead of print])
    View Abstract
  • Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus.
    (Yokoyama H, et.al. Metabolism. 2007 Nov;56(11):1458-63.)
    View Abstract
  • The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state.
    (Rudijanto A.Acta Med Indones. 2007 Jan-Mar;39(1):36-43.)
    View Abstract

> top

Drug Therapy

  • Bioenergetic and antioxidant properties of coenzyme Q10: recent developments.
    (Littarru GP, et.al. Mol Biotechnol. 2007 Sep;37(1):31-7. Review.)
    View Abstract
  • Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer.
    (Clemmons DR.Nat Rev Drug Discov. 2007 Oct;6(10):821-33. Review.)
    View Abstract
  • Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?
    (Grundy SM.Am J Med. 2007 Sep;120(9 Suppl 1):S3-8; discussion S9. Review.)
    View Abstract
  • Statin-Treated Familial Hypercholesterolemia Patients with Coronary Heart Disease and Pronounced Atherosclerosis Do Not Have More Brain Lesions than Healthy Controls in Later Middle Age.
    (Soljanlahti S, et.al. Acta Radiol. 2007;48(8):894-899.)
    View Abstract
  • Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?
    (Athyros VG, et.al. Expert Opin Pharmacother. 2007 Oct;8(14):2267-77.)
    View Abstract
  • Cerebrovascular effects of cilostazol in patients with atherosclerotic disease.
    (Ameriso SF, et.al. J Stroke Cerebrovasc Dis. 2006 Nov-Dec;15(6):273-6.)
    View Abstract
  • PKC Isozymes in Chronic Cardiac Disease: Possible Therapeutic Targets?
    (Churchill E, et.al. Annu Rev Pharmacol Toxicol. 2007 Oct 5; [Epub ahead of print])
    View Abstract
  • CB2 receptors as new therapeutic targets for liver diseases.
    (Lotersztajn S, et.al. Br J Pharmacol. 2007 Oct 22; [Epub ahead of print])
    View Abstract
  • c-Jun N-terminal kinases as potential therapeutic targets.
    (Salh B.Expert Opin Ther Targets. 2007 Oct;11(10):1339-53. Review.)
    View Abstract
  • Insights into atherosclerosis therapy in antiphospholipid syndrome.
    (Belizna CC, et.al. Autoimmun Rev. 2007 Nov;7(1):46-51. Epub 2007 Jul 18.)
    View Abstract
  • Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.
    (Marre M, et.al. Diab Vasc Dis Res. 2007 Sep;4(3):163-73.)
    View Abstract
  • BAY x 1005 attenuates atherosclerosis in apoE/LDLR - double knockout mice.
    (Jawien' J, et.al. J Physiol Pharmacol. 2007 Sep;58(3):583-8.)
    View Abstract
  • PPARalpha Ligands Reduce PCB-Induced Endothelial Activation: Possible Interactions in Inflammation and Atherosclerosis.
    (Arzuaga X, et.al. Cardiovasc Toxicol. 2007;7(4):264-72. Epub 2007 Oct 23.)
    View Abstract
  • Pioglitazone increases macrophage apoptosis and plaque necrosis in advanced atherosclerotic lesions of nondiabetic low-density lipoprotein receptor-null mice.
    (Thorp E, et.al. Circulation. 2007 Nov 6;116(19):2182-90. Epub 2007 Oct 22.)
    View Abstract
  • Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
    (Ali F, et.al. J Thromb Haemost. 2007 Oct 10; [Epub ahead of print])
    View Abstract
  • Thiazolidinediones and vascular damage.
    (Goldberg RB.Curr Opin Endocrinol Diabetes Obes. 2007 Apr;14(2):108-15.)
    View Abstract
  • Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-kappaB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells.
    (Lin CP, et.al. J Biomed Sci. 2007 Sep 30; [Epub ahead of print])
    View Abstract
  • Rapamycin promotes vascular smooth muscle cell differentiation through IRS-1/PI 3-Kinase/Akt2 feedback signaling.
    (Martin KA, et.al. J Biol Chem. 2007 Sep 30; [Epub ahead of print])
    View Abstract
  • Inhibition of Interleukin-1{beta}-Induced Group IIA Secretory Phospholipase A2 Expression by Peroxisome Proliferator-Activated Receptors (PPARs) in Rat Vascular Smooth Muscle Cells: Cooperation between PPAR{beta} and the Proto-Oncogene BCL-6.
    (Ravaux L, et.al. Mol Cell Biol. 2007 Dec;27(23):8374-8387. Epub 2007 Oct 1.)
    View Abstract

> top

Gender

  • Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    (Vitale C, et.al. Climacteric. 2007 Oct;10 Suppl 2:16-20.)
    View Abstract
  • Gender-specific effect of metabolic syndrome on rate adjusted QT interval in middle-aged participants of an atherosclerosis prevention program.
    (Strohmer B, et.al. Wien Klin Wochenschr. 2007 Sep;119(17-18):544-552.)
    View Abstract

> top

Genetics of CVD

  • Characterization of a murine model of fetal programming of atherosclerosis.
    (Goharkhay N, et.al. Am J Obstet Gynecol. 2007 Oct;197(4):416.e1-5.)
    View Abstract
  • Molecular scanning of the human carboxypeptidase E gene for mutations in Chinese subjects with coronary atherosclerosis.
    (Jia EZ, et.al. Mol Cell Biochem. 2007 Oct 24; [Epub ahead of print])
    View Abstract
  • Genome-wide association studies in aging-related processes such as diabetes mellitus, atherosclerosis and cancer.
    (Kronenberg F.Exp Gerontol. 2007 Sep 29; [Epub ahead of print])
    View Abstract
  • Congenital Growth Hormone Deficiency and Atherosclerosis: Effects of GH Replacement in GH-Naive Adults.
    (Oliveira JL, et.al. J Clin Endocrinol Metab. 2007 Oct 2; [Epub ahead of print])
    View Abstract
  • Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease.
    (Fujimoto H, et.al. Eur Heart J. 2007 Oct 29; [Epub ahead of print])
    View Abstract
  • Mapping, Genetic Isolation, and Characterization of Genetic Loci That Determine Resistance to Atherosclerosis in C3H Mice.
    (Wang SS, et.al. Arterioscler Thromb Vasc Biol. 2007 Oct 4; [Epub ahead of print])
    View Abstract
  • Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: The Cardiovascular Risk in Young Finns Study.
    (Collings A, et.al. Scand J Clin Lab Invest. 2007 Oct 12;:1-12 [Epub ahead of print])
    View Abstract

> top

Imaging

  • Intraplaque hemorrhage assessed by high-resolution magnetic resonance imaging and C-reactive protein in carotid atherosclerosis.
    (Albuquerque LC, et.al. J Vasc Surg. 2007 Oct 4; [Epub ahead of print])
    View Abstract
  • High-resolution contrast-enhanced MRI of atherosclerosis with digital cardiac and respiratory gating in mice.
    (Alsaid H, et.al. Magn Reson Med. 2007 Oct 29; [Epub ahead of print])
    View Abstract
  • FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries.
    (Bural GG, et.al. Eur J Nucl Med Mol Imaging. 2007 Oct 24; [Epub ahead of print])
    View Abstract
  • Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide.
    (McAteer MA, et.al. Arterioscler Thromb Vasc Biol. 2007 Oct 25; [Epub ahead of print])
    View Abstract
  • Quantification of Carotid Atherosclerotic Plaque Components using Feature Space Analysis and Magnetic Resonance Imaging.
    (Karmonik C, et.al. Conf Proc IEEE Eng Med Biol Soc. 2006;1:3102-5.)
    View Abstract
  • Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients.
    (Schukro C, et.al. J Diabetes Complications. 2007 Nov-Dec;21(6):381-6.)
    View Abstract
  • In Vivo Optical Coherence Tomography (OCT) of Experimental Thrombosis in a Rabbit Carotid Model.
    (Meng L, et.al. Heart. 2007 Oct 18; [Epub ahead of print])
    View Abstract
  • Dynamic MR Angiography of Upper Extremity Vascular Disease: Pictorial Review.
    (Stepansky F, et.al. Radiographics. 2007 Oct 29; [Epub ahead of print])
    View Abstract

> top

Immunology

  • Systemic antiphospholipid syndrome and atherosclerosis.
    (Jara LJ, et.al. Clin Rev Allergy Immunol. 2007 Apr;32(2):172-7.)
    View Abstract
  • CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall.
    (Galkina E, et.al. Circulation. 2007 Oct 16;116(16):1801-11. Epub 2007 Oct 1.)
    View Abstract
  • Th1 polarized response induced by intramuscular DNA-HSP65 immunization is preserved in experimental atherosclerosis.
    (Fonseca DM, et.al. Braz J Med Biol Res. 2007 Nov;40(11):1495-504.)
    View Abstract

> top

Inflammation

  • Radiolabeled monocyte chemotactic protein 1 for the detection of inflammation in experimental atherosclerosis.
    (Hartung D, et.al. J Nucl Med. 2007 Nov;48(11):1816-21. Epub 2007 Oct 17.)
    View Abstract
  • Chlamydia pneumoniae accompanied by inflammation is associated with the progression of atherosclerosis in CAPD patients: a prospective study for 3 years.
    (Kim DK, et.al. Nephrol Dial Transplant. 2007 Oct 15; [Epub ahead of print])
    View Abstract
  • Role of inflammation in atherosclerosis.
    (Spagnoli LG, et.al. J Nucl Med. 2007 Nov;48(11):1800-15. Epub 2007 Oct 17.)
    View Abstract

> top

Lipid and Lipoprotein Metabolism

  • Reverse cholesterol transport and atherosclerosis. A mini review.
    (Cucuianu M, et.al. Rom J Intern Med. 2007;45(1):17-27.)
    View Abstract
  • Peculiarities of coronary artery atherosclerosis in male patients of Yakut nationality with ischemic heart disease.
    (Romanova AN, et.al. Alaska Med. 2006;49(2 Suppl):127-30.)
    View Abstract

> top

Liver Disease

  • Evaluation of Metabolic Syndrome Frequency and Carotid Artery Intima-media Thickness as Risk Factors for Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease.
    (Aygun C, et.al.
    Dig Dis Sci. 2007 Oct 16; [Epub ahead of print])
    View Abstract

> top

Menopause

  • Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    (Vitale C, et.al. Climacteric. 2007 Oct;10 Suppl 2:16-20.)
    View Abstract
  • Early carotid atherosclerosis in women: results of an ultrasonographic study measuring carotid artery intima-media thickness.
    (Santo Signorelli S, et.al. J Stroke Cerebrovasc Dis. 2005 Jul-Aug;14(4):162-6.)
    View Abstract

> top

Metabolic Syndrome

  • The relationship of three common definitions of the metabolic syndrome with sub-clinical carotid atherosclerosis.
    (Paras E, et.al. Atherosclerosis. 2007 Oct 22; [Epub ahead of print])
    View Abstract
  • Gender-specific effect of metabolic syndrome on rate adjusted QT interval in middle-aged participants of an atherosclerosis prevention program.
    (Strohmer B, et.al. Wien Klin Wochenschr. 2007 Sep;119(17-18):544-552.)
    View Abstract

> top

Nutrition and Diet

  • Effects of high-carbohydrate and high fat diet on formation of foam cells and expression of TNF-alpha in Rattus novergicus.
    (Haidar, et.al. Acta Med Indones. 2007 Jul-Sep;39(3):119-23.)
    View Abstract
  • Soybean protein hydrolysate improves plasma and liver lipid profiles in rats fed high-cholesterol diet.
    (Yang SC, et.al. J Am Coll Nutr. 2007 Oct;26(5):416-23.)
    View Abstract
  • Nutrition and Cardiovascular Disease.
    (Getz GS, et.al. Arterioscler Thromb Vasc Biol. 2007 Oct 22; [Epub ahead of print])
    View Abstract
  • Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression.
    (Thampi P, et.al. Atherosclerosis. 2007 Oct 18; [Epub ahead of print])
    View Abstrac
    t

> top

Obesity

  • Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    (Meyers MR, et.al. Curr Opin Endocrinol Diabetes Obes. 2007 Oct;14(5):365-9.)
    View Abstract
  • Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity.
    (Sánchez-Vera I, et.al. Metabolism. 2007 Nov;56(11):1527-33.)
    View Abstract

> top